Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region-Reference-Cited by-同舟云学术

Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region

Published:2016-02-05 Issue:1 Volume:15 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Toma Ildiko,Kim Paul J.,Dash Rajesh,McConnell Michael V.,Nishimura Dwight,Harnish Phillip,Yang Phillip C.

Funder

Boehringer Ingelheim (US)

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-016-0348-y

Reference33 articles.

1. Boden WE, Taggart DP. Diabetes with coronary disease—a moving target amid evolving therapies? N Engl J Med. 2009;360(24):2570–2. doi: 10.1056/NEJMe0904090 .

2. Maahs DM, Daniels SR, de Ferranti SD, Dichek HL, Flynn J, Goldstein BI, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014;130(17):1532–58. doi: 10.1161/CIR.0000000000000094 .

3. Cea Soriano L, Johansson S, Stefansson B, Rodriguez LA. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14:38. doi: 10.1186/s12933-015-0204-5 .

4. Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis. 2015;9(6):412–24. doi: 10.1177/1753944715594528 .

5. Mercier K, Smith H, Biederman J. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors. Prim Care. 2014;41(4):765–78. doi: 10.1016/j.pop.2014.08.002 .

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging in experimental models of diabetes;Acta Diabetologica;2021-11-15

2. Myocardial Viability Imaging using Manganese‐Enhanced MRI in the First Hours after Myocardial Infarction;Advanced Science;2021-04-02

3. Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats;Acta Pharmacologica Sinica;2021-03-12

4. Technical Aspects of in vivo Small Animal CMR Imaging;Frontiers in Physics;2020-06-10

5. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction;International Journal of Nanomedicine;2018-10